Jefferies uses ten charts to emphasize that China's technology leadership is becoming a structural investment theme

Overview

This is a Jefferies Global Washington Strategy thematic report titled "China's Tech Leadership: Our 10 Best Charts." The report focuses on the rise of China's technological capabilities and uses ten sets of charts and external data sources to compare China with the United States and other major economies in scientific research, industrial investment, strategic technology, and space capabilities. The core conclusion is that China's technological breakthroughs are not short-term cyclical fluctuations, but a structural trend that has already shown early effects in areas such as telecommunications, automobiles, and AI.

Core views

The report argues that China is becoming globally leading or close to the U.S. across multiple key technology dimensions. Evidence includes the leading position of Chinese research institutions in the Nature Index, the rapid rise in China's share of highly cited papers in critical technologies, R&D spending surpassing that of the U.S. on a PPP basis, the world's highest patent application volume, DeepSeek's usage on OpenRouter exceeding that of leading U.S. labs, declining import dependence in strategic industries, leadership in key defense technology research, clean technology factory investment far exceeding that of the U.S., and China's emergence as the only serious challenger to the U.S. across five frontier fields: AI, biotechnology, semiconductors, space, and quantum. In investment terms, the report recommends that investors reassess the impact of China's technological rise on Western equities and consider direct allocation to China-related technology exposure.

Analysis framework

The report adopts a chart-driven cross-country comparative approach, combining sources including the Nature Index, ASPI Critical Technology Tracker, ITIF, WIPO, OpenRouter, Rhodium Group, BloombergNEF, Belfer Center, and Novaspace, covering scientific output, R&D investment, patents, AI model usage, trade dependence, defense technology, clean technology capex, frontier technology indices, and government space spending. Its analytical focus is not corporate financial modeling, but identifying changes in the technology competition landscape and investment themes through multidimensional leading indicators.

Methodology notes

• Thematic strategyTop 10 charts evidence framework

  Use ten sets of cross-country indicators to validate China's technology leadership

  The report does not use a traditional single-stock valuation model, but instead selects ten representative indicators to form a thematic judgment from the perspectives of scientific research, industrial capex, strategic autonomy, and state support capabilities.

• Technology competition analysisChina-U.S. critical technology comparison

  Compare the relative positions of China and the United States in high-impact research, AI, semiconductors, quantum, space, and defense technology

  The report positions China as the only country outside the United States with systematic challenge capabilities across five major frontier technology sectors, and emphasizes the clear gap between China/U.S. and Europe/Japan.

• Investment implicationsStructural disruption assessment

  The repricing impact of China's technological rise on Western equities and China technology exposure

  The report believes that China's technology disruption is structural rather than cyclical, so investors need to pay attention both to Western companies under pressure and to Chinese technology assets that may benefit.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• China technology-related equities and industry chain assets

  Potential beneficiary assets

  Strengths

  Benefit from expanded R&D investment, patent accumulation, improved AI application, reduced import dependence, and leading clean technology capital expenditure.

  Weaknesses

  The report does not provide specific company earnings forecasts, valuations, or stock ratings, so further asset screening is still needed to implement the theme.

  Comparison

  Compared with the U.S., Europe, and Japan, China shows faster catch-up or leadership across multiple scientific research and industrial investment indicators.

  Risks

  Geopolitics, export controls, valuation volatility, policy implementation differences, and uncertainty in technology commercialization.

• U.S. and Western technology, industrial, and clean technology equities

  Potentially impacted assets

  Strengths

  The U.S. still maintains leadership in the five major frontier technology indices and in government space spending.

  Weaknesses

  China is rapidly catching up or leading in high-impact scientific research, patents, clean technology capital expenditure, and some AI usage indicators, which may compress existing leadership advantages.

  Comparison

  The report describes China as the only serious near-peer competitor to the U.S., while Europe and Japan lag significantly behind China and the U.S. in the composite index.

  Risks

  Intensifying competition from China may affect market share, pricing power, supply chain control, and long-term valuation premiums.

• Clean technology manufacturing and equipment industry chain

  China capex leadership theme

  Strengths

  Mainland China's clean technology factory investment in 2025 is expected to be about $104 billion, significantly higher than the U.S.

  Weaknesses

  High capital expenditure may bring capacity cycles, margin pressure, and trade friction.

  Comparison

  Relevant U.S. investment in 2025 is about $9 billion, with China at about 12 times that level.

  Risks

  Changes in subsidy policy, overseas tariffs, overcapacity, and global demand volatility.

• AI models and application ecosystem

  China AI usage improvement theme

  Strengths

  DeepSeek's normalized token usage on OpenRouter has risen rapidly and surpassed leading U.S. models, indicating improving application adoption.

  Weaknesses

  Usage on a single platform cannot fully represent model capability, revenue quality, or enterprise penetration.

  Comparison

  The report compares DeepSeek usage with models from leading U.S. labs, emphasizing the rise of China's AI influence.

  Risks

  Rapidly changing model competition, compute constraints, regulatory requirements, and commercialization uncertainty.

Key data

• Top 10 global high-impact research institutions9 are from ChinaIn Nature Index 2026, the Chinese Academy of Sciences ranks first, and Zhejiang University surpasses Harvard to become the highest-ranked academic institution.
• Share of highly cited papers in critical technologiesChina about 47%, U.S. about 9%ASPI data show that China's share rose from about 5% in 2005 to about 47% in 2025, while the U.S. fell from about 40% to about 9%.
• 2024 R&D spending on a PPP basisChina about $1.03 trillion, U.S. about $1.01 trillionITIF estimates show that China has slightly surpassed the U.S.; China's actual R&D spending has grown at an annual rate of more than 12% since 2004.
• 2024 patent applicationsChina about 1.8 millionWIPO data show that China is 3.6 times the U.S. total of about 503,000, 4.3 times Japan's about 421,000, and exceeds the combined total of the other nine countries in the top ten.
• DeepSeek normalized token usage on OpenRouterAbout 8,600 in July 2026The report says DeepSeek rose rapidly from near zero in early 2025 and surpassed leading U.S. models.
• China's import dependence in strategic industriesSignificantly declinedRhodium data show that since 2004, the share of sub-industries in which China's imports were more than double exports has fallen sharply across eight strategic industries including aerospace, advanced electronics, robotics, and power.
• Share of research in key defense technologiesChina leads the U.S. in 18 key defense fieldsASPI covers areas including hypersonics, quantum computing, autonomous underwater vehicles, drones, and electronic warfare.
• 2025 clean technology factory capital expenditureMainland China about $104 billion, U.S. about $9 billionBloombergNEF data imply a gap of about 12 times; China has averaged about $95 billion annually since 2023.
• 2025 critical and emerging technologies indexU.S. about 84, China about 65, Europe about 42, Japan about 24The Belfer Center index covers AI, biotechnology, semiconductors, space, and quantum.
• 2024 government space spendingChina about $19.9 billion, U.S. about $79.7 billionNovaspace data show China ranks second globally, at about three times the level of Japan, the EU/ESA, and Russia.

Impact & implications

The investment implication of the report is that the rise in China's technological capabilities may reshape the competitive landscape for global technology, industrial, and strategic assets. For Western equities, the risk lies in pricing, technology, and supply chain competitive pressure from Chinese companies or state-supported industrial capabilities; for Chinese technology assets, the opportunity lies in the long-term allocation value created by R&D, patents, AI applications, clean technology capacity, and strategic industrial self-reliance. The report does not provide a specific stock list or buy/sell ratings, so it is more suitable as an input for thematic allocation and risk exposure assessment rather than as a single-security investment recommendation.

Risks

• The report is thematic strategy research and does not provide stock ratings, target prices, earnings forecasts, or valuation sensitivities, so it cannot directly replace single-stock research.
• Multiple indicators come from different third-party institutions, including paper share, PPP R&D spending, patent applications, platform usage, and government spending, and these metrics cannot be simply added together.
• Leadership in scientific research and patents does not necessarily equate to commercial success or shareholder returns; corporate profitability and returns on capital require further verification.
• The China technology theme faces risks from geopolitics, export controls, tariffs, capital market access, and regulatory changes.
• High capital expenditure in clean technology may lead to overcapacity and price competition, and may not fully translate into profit growth.
• OpenRouter usage is a platform-level metric and may be influenced by platform structure, user base, and short-term model popularity.

What to watch

• Whether commercialization progress in China's AI, semiconductors, quantum, space, and biotechnology sectors continues to deliver.
• Whether China-U.S. export controls, tariffs, and technology policies change the competitive landscape of industry chains.
• Whether China's clean technology capital expenditure translates into global market share and sustainable profit margins.
• Changes in usage, enterprise adoption, revenue models, and compute constraints for Chinese AI models such as DeepSeek.
• Whether the decline in China's import dependence in strategic industries continues to expand into fields such as aerospace, advanced electronics, robotics, and power.
• Whether earnings guidance from Western technology and industrial companies begins to reflect pressure from Chinese competition.
• Whether more than 40 subsequent related Jefferies studies provide more specific clues on industries, companies, or asset allocation.